This cost-effectiveness analysis of care options for group A streptococcus patients is the first to include community pharmacy as a possible point of care.
Donald G. Klepser, PhD, MBA
Advertisement
Articles by Donald G. Klepser, PhD, MBA
In this database analysis, greater adherence was observed for once-daily dosing compared with twice-daily dosing with chronic-use prescription medications used by patients with cardiovascular disease.
In his Editorial, Dr. Klepser considers the effectiveness and the future of value-based insurance design.
Advertisement
Latest Updated Articles
- Are Patent Expirations the Answer to Improving Patient Adherence?
December 1st 2008
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
New York Experts Push for Coordinated Obesity Care Teams
4
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
5